Eclipse Regenesis, Inc.
Mountain View, CA Doing business as Eclipse Regenesis Inc.
- UEI
- NNJ5XHMGNKS8
- CAGE
- 84F74
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2495 Hospital Dr #300, Mountain View, CA 94040, USA
- Website
- eclipseregenesis.com
- Founded
- 2017
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase II: endoluminal fixation of a distraction enterogenesis device -the broader impact/commercial potential of… | National Science Foundation | $1,470,358 | |
| Intestinal lengthening via distraction enterogenesis for the treatment of short bowel syndrome - project summary short… | National Institute of Diabetes and Digestive and Kidney Diseases | $4,894,640 | |
| Sbir phase i: endoluminal fixation of a distraction enterogenesis device | Division of Industrial Innovation | $256,000 |
About Eclipse Regenesis, Inc.
Eclipse Regenesis, Inc. is a for-profit manufacturer of medical devices registered to do business with the federal government through SAM.gov since May 2018. The company develops innovative technologies to treat short bowel syndrome.
Eclipse Regenesis has received over $4.4 million in federal grants to support the development and testing of a distraction enterogenesis device to lengthen the intestine and restore natural nutrient absorption for short bowel syndrome patients. This includes a $970,484 National Science Foundation grant in 2023 to develop a minimally invasive delivery method, a $3.1 million National Institutes of Health grant in 2021 to conduct preclinical animal testing and a first-in-human clinical trial of the device, and a $256,000 National Science Foundation Small Business Innovation Research grant in 2020 to develop tissue anchors to fixate the device in the intestine. Eclipse Regenesis also received a $50,000 subaward from the University of California, San Francisco in support of medical device design and development services provided by Meraqi Medical.
Quick answers
What is Eclipse Regenesis, Inc.'s UEI?
Eclipse Regenesis, Inc.'s Unique Entity ID (UEI) in SAM.gov is NNJ5XHMGNKS8.
What is Eclipse Regenesis, Inc.'s CAGE code?
Eclipse Regenesis, Inc.'s CAGE code is 84F74.
Where is Eclipse Regenesis, Inc. located?
Eclipse Regenesis, Inc.'s physical address in SAM.gov is 2495 Hospital Dr #300, Mountain View, CA 94040, USA.
Is Eclipse Regenesis, Inc. registered in SAM.gov?
Yes. Eclipse Regenesis, Inc.'s SAM.gov registration is active through June 1, 2027.
What is Eclipse Regenesis, Inc.'s most recent federal award?
Eclipse Regenesis, Inc.'s most recent federal grant award is Sbir phase II: endoluminal fixation of a distraction enterogenesis device -the broader impact/commercial potential of… (2232550), from National Science Foundation, on May 1, 2023.
On GovTribe
See Eclipse Regenesis, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors